业内人的“针砭时弊”:AI医疗界的3大乱象以及如何评价医学人工智能的成果?

2017-08-30 李雨陈 雷锋网

用虚拟助手分析声音以确定健康状况影响身心健康和医疗保健的方法非常有趣。通过对声音的解读,人工智能平台或许可以检测到抑郁症,甚至可能是潜在的慢性疾病,如心脏病。例如,一家名为 Beyond Verbal 的创业公司正在开发可与 Alexa 等进行合作的分析工具,以此了解行为和声音模式。该公司首席执行官 Yuval Mor 在6月份表示:“在不久的将来,我们的目标是为我们的功能集上添加声乐生物标记分析

用虚拟助手分析声音以确定健康状况

影响身心健康和医疗保健的方法非常有趣。通过对声音的解读,人工智能平台或许可以检测到抑郁症,甚至可能是潜在的慢性疾病,如心脏病。

例如,一家名为 Beyond Verbal 的创业公司正在开发可与 Alexa 等进行合作的分析工具,以此了解行为和声音模式。

该公司首席执行官 Yuval Mor 在6月份表示:“在不久的将来,我们的目标是为我们的功能集上添加声乐生物标记分析,使虚拟助手能够分析你的声音,以确定具体的健康状况。”

总部位于芝加哥的咨询公司 West Monroe Partners 的生命科学实践主管 Anthony Chambers 表示,近期,随着技术不断完善,医院希望能够感受到 AI 和 EI 带来的好处,同时他们也需要好好考虑在何处以及如何部署技术。

雷锋网了解到,在医疗保健领域,人工智能应用的案例种类繁多。支持语音的虚拟助手可帮助临床医生访问笔记或让外科医生看到安全检查表。它们可以帮助工作人员处理编码和转录作业。一个情感智能的 AI,无论是陪伴某人(例如谈话治疗)还是帮助我们执行某些任务(例如刑事审讯),它都有很多潜在的优势。

“医院已经意识到他们坐拥大量数据,”Chambers 表示,“过去几年,他们开始采取 Narrative Science,自然语言生成和其他机器学习技术来获得竞争优势。我们看到我们的客户在病人护理过程中进行识别和预测等方面取得了很大进展。”

“很多医院现在正在使用 AI 和机器学习来预测问题在哪里:在哪里可以获得更高的吞吐量,护理管理过程如何更高效。“他说。但在未来的几年里,可能是病人自己在 AI 平台上花费大量的时间 -——这就是情感智能开始变得越来越重要的地方。

Chambers 说:“真正令人着迷的是,我们还没有看到它,但是我们看到关于它的讨论 ——是关于护理质量的潜在价值。“这仍然是一个未开发的‘处女地’,与人工智能相结合的情感智能的未来可能会出现。”

情绪智能如何支持护理的过程?

医院和制药公司正在探索这些平台如何帮助临床试验管理。 Chambers 说,自然语言处理工具可以帮助收集数据并预测结果,“同时向医师和制药公司提供几乎实时的反馈。”考虑到临床试验对病人的压力,这一点尤其有用。提供一种较少侵入性的方式将结果传达给供应商和制药公司可能是一个福音。“如果我们可以使用互动机器人,那么患者随后就可以通过智能手机或某些东西进行交谈,这可能是一个改变游戏规则的因素,因为临床试验对人群的压力非常大,而且开展试验的费用也会增加。“

Chambers 表示,他也看到越来越多的供应商开始把目光放在病人的“入院和出院”的医疗过程中。他补充道:“想想面部表情,手势,节奏和语调。如果你将这些碎片分解成聊天机器人、机器人或其他与人类的互动点,那就成了人工智能和大数据算法可以用来评估结果的指标或数据。”

随着医院越来越多地关注这些有前瞻性的应用,有一些很重要的问题, CIO 们和其他 IT 专家应该记住,Chambers 说。

对于希望利用 AI 和 EI 来帮助客户体验或提高护理质量的机构来说,我认为医院或临床医生要决定的第一个问题是情绪智能如何支持护理的过程。“情绪智能是否会取代人与人的互动?如果情绪智能取代了(人与人的互动),它将在哪些方面支持病人,我们该如何使用这种交流方式?

尽管在应用前景上,人工智能存在很多优势,但还存在很多道德问题和风险。我们是否可以让 AI 陪伴老年痴呆症患者,明明它只是个机器,不会有感情,我们却依旧相信它有感情,这是否正确?显然不是。

Chambers 说:“因为你真的在改变着你如何与病人互动的模式。”“在病人的治疗周期中,你看到需求了吗?”

假设这些问题已经解决,还有一个重要的事情要考虑。他说:“你打算怎么处理这些数据?这是病人级的数据,是实时的。然后把它变成电子健康记录吗?用社交媒体来标记它吗?索赔数据是否使用它?它是如何整合的?”

他说,隐私问题“有点让人气馁”。“你如何管理病人的情商?我不知道。这些是我们正在努力解决的问题。但医院和医疗保健公司有机会在这个领域发挥领导作用。”

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1755260, encodeId=e3dd1e5526006, content=<a href='/topic/show?id=14e123562d0' target=_blank style='color:#2F92EE;'>#乱象#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23562, encryptionId=14e123562d0, topicName=乱象)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=842136851119, createdName=zhangjingnwpu, createdTime=Wed Dec 20 09:03:00 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1967306, encodeId=29da196e30690, content=<a href='/topic/show?id=89493400990' target=_blank style='color:#2F92EE;'>#医学人工智能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34009, encryptionId=89493400990, topicName=医学人工智能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5e117, createdName=lujian, createdTime=Sat Jan 06 17:03:00 CST 2018, time=2018-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1755506, encodeId=0fd21e5550662, content=<a href='/topic/show?id=04842203c5' target=_blank style='color:#2F92EE;'>#AI医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2203, encryptionId=04842203c5, topicName=AI医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=617f36934090, createdName=szhvet, createdTime=Mon Jul 30 03:03:00 CST 2018, time=2018-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374549, encodeId=363513e45491a, content=<a href='/topic/show?id=1aed3509902' target=_blank style='color:#2F92EE;'>#医疗界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35099, encryptionId=1aed3509902, topicName=医疗界)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ca5383, createdName=bbjsj_1979, createdTime=Fri Sep 01 13:03:00 CST 2017, time=2017-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444253, encodeId=00bc14442537f, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Fri Sep 01 13:03:00 CST 2017, time=2017-09-01, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1755260, encodeId=e3dd1e5526006, content=<a href='/topic/show?id=14e123562d0' target=_blank style='color:#2F92EE;'>#乱象#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23562, encryptionId=14e123562d0, topicName=乱象)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=842136851119, createdName=zhangjingnwpu, createdTime=Wed Dec 20 09:03:00 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1967306, encodeId=29da196e30690, content=<a href='/topic/show?id=89493400990' target=_blank style='color:#2F92EE;'>#医学人工智能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34009, encryptionId=89493400990, topicName=医学人工智能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5e117, createdName=lujian, createdTime=Sat Jan 06 17:03:00 CST 2018, time=2018-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1755506, encodeId=0fd21e5550662, content=<a href='/topic/show?id=04842203c5' target=_blank style='color:#2F92EE;'>#AI医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2203, encryptionId=04842203c5, topicName=AI医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=617f36934090, createdName=szhvet, createdTime=Mon Jul 30 03:03:00 CST 2018, time=2018-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374549, encodeId=363513e45491a, content=<a href='/topic/show?id=1aed3509902' target=_blank style='color:#2F92EE;'>#医疗界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35099, encryptionId=1aed3509902, topicName=医疗界)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ca5383, createdName=bbjsj_1979, createdTime=Fri Sep 01 13:03:00 CST 2017, time=2017-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444253, encodeId=00bc14442537f, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Fri Sep 01 13:03:00 CST 2017, time=2017-09-01, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1755260, encodeId=e3dd1e5526006, content=<a href='/topic/show?id=14e123562d0' target=_blank style='color:#2F92EE;'>#乱象#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23562, encryptionId=14e123562d0, topicName=乱象)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=842136851119, createdName=zhangjingnwpu, createdTime=Wed Dec 20 09:03:00 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1967306, encodeId=29da196e30690, content=<a href='/topic/show?id=89493400990' target=_blank style='color:#2F92EE;'>#医学人工智能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34009, encryptionId=89493400990, topicName=医学人工智能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5e117, createdName=lujian, createdTime=Sat Jan 06 17:03:00 CST 2018, time=2018-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1755506, encodeId=0fd21e5550662, content=<a href='/topic/show?id=04842203c5' target=_blank style='color:#2F92EE;'>#AI医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2203, encryptionId=04842203c5, topicName=AI医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=617f36934090, createdName=szhvet, createdTime=Mon Jul 30 03:03:00 CST 2018, time=2018-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374549, encodeId=363513e45491a, content=<a href='/topic/show?id=1aed3509902' target=_blank style='color:#2F92EE;'>#医疗界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35099, encryptionId=1aed3509902, topicName=医疗界)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ca5383, createdName=bbjsj_1979, createdTime=Fri Sep 01 13:03:00 CST 2017, time=2017-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444253, encodeId=00bc14442537f, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Fri Sep 01 13:03:00 CST 2017, time=2017-09-01, status=1, ipAttribution=)]
    2018-07-30 szhvet
  4. [GetPortalCommentsPageByObjectIdResponse(id=1755260, encodeId=e3dd1e5526006, content=<a href='/topic/show?id=14e123562d0' target=_blank style='color:#2F92EE;'>#乱象#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23562, encryptionId=14e123562d0, topicName=乱象)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=842136851119, createdName=zhangjingnwpu, createdTime=Wed Dec 20 09:03:00 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1967306, encodeId=29da196e30690, content=<a href='/topic/show?id=89493400990' target=_blank style='color:#2F92EE;'>#医学人工智能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34009, encryptionId=89493400990, topicName=医学人工智能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5e117, createdName=lujian, createdTime=Sat Jan 06 17:03:00 CST 2018, time=2018-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1755506, encodeId=0fd21e5550662, content=<a href='/topic/show?id=04842203c5' target=_blank style='color:#2F92EE;'>#AI医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2203, encryptionId=04842203c5, topicName=AI医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=617f36934090, createdName=szhvet, createdTime=Mon Jul 30 03:03:00 CST 2018, time=2018-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374549, encodeId=363513e45491a, content=<a href='/topic/show?id=1aed3509902' target=_blank style='color:#2F92EE;'>#医疗界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35099, encryptionId=1aed3509902, topicName=医疗界)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ca5383, createdName=bbjsj_1979, createdTime=Fri Sep 01 13:03:00 CST 2017, time=2017-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444253, encodeId=00bc14442537f, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Fri Sep 01 13:03:00 CST 2017, time=2017-09-01, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1755260, encodeId=e3dd1e5526006, content=<a href='/topic/show?id=14e123562d0' target=_blank style='color:#2F92EE;'>#乱象#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23562, encryptionId=14e123562d0, topicName=乱象)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=842136851119, createdName=zhangjingnwpu, createdTime=Wed Dec 20 09:03:00 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1967306, encodeId=29da196e30690, content=<a href='/topic/show?id=89493400990' target=_blank style='color:#2F92EE;'>#医学人工智能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34009, encryptionId=89493400990, topicName=医学人工智能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5e117, createdName=lujian, createdTime=Sat Jan 06 17:03:00 CST 2018, time=2018-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1755506, encodeId=0fd21e5550662, content=<a href='/topic/show?id=04842203c5' target=_blank style='color:#2F92EE;'>#AI医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2203, encryptionId=04842203c5, topicName=AI医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=617f36934090, createdName=szhvet, createdTime=Mon Jul 30 03:03:00 CST 2018, time=2018-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374549, encodeId=363513e45491a, content=<a href='/topic/show?id=1aed3509902' target=_blank style='color:#2F92EE;'>#医疗界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35099, encryptionId=1aed3509902, topicName=医疗界)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ca5383, createdName=bbjsj_1979, createdTime=Fri Sep 01 13:03:00 CST 2017, time=2017-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444253, encodeId=00bc14442537f, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Fri Sep 01 13:03:00 CST 2017, time=2017-09-01, status=1, ipAttribution=)]
    2017-09-01 huagfeg